REFERENCES
- Alvarez-Lerma F, NoIla J, Palomar M, Leon MA. Treat-ment approach for fungal infections in critically ill patients ad-mitted to intensive care units: results of a multicenter survey. [Article in Spanish]. Enferm Infecc Microbiol Clin 2003; 21: 83–88.
- Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, et al. Clin Infect Dis 2003; 37: 1172–1177.
- Ostrosky-Zeichner L. Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit? Crit Care Med 2004; 32: 2552-2553.
- Gavaldà J, Ruiz I. Guidelines for the treatment of invasive fungal infection. Invasive fungal infection by Candida spp. Inva-sive Fungal Infection Study Group (MICOMED) and Infection in Transplantation Study Group (GESITRA) of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC). [Arti-cle in Spanish]. Enferm Infecc Microbiol Clin 2003; 21: 498–508.
- Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin In-fect Dis 2004; 38: 161–189.
- Garnacho-Montero J, Leon Gil C, Almirante B, Alvarez Lerma F, Cuenca Estrella M, Garcia Rodriguez JA, et al. Recomendaciones terapéuticas en el paciente critico no neu-tropénico. Conferencia de Consenso. Conclusiones. Med Intensiva 2005 (Suppl 3): 43-52.
- León C, Ruiz-Santana S, Saavedra P, Almirante B, NoIla-Salas J, Alvarez-Lerma F, et al. A bedside scoring system (“Can-dida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006; 34: 730–737.
- Ruiz-Santana S, León C, Saavedra P, Almirante B. The “Seville score": a new preemptive antifungal therapy approach for candida colonization in non-neutropenic critically ill patients. Crit Care Med 2004; 32 (Suppl): All.
- Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial inva-sive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007; 26: 271–276.
- Alvarez-Lerma F, Palomar M, Leon C, Olaechea P, Cerda E, Bermejo B. Indicaciones para el tratamiento antiffingico en pacientes ingresados en UCI. Enferm Infecc Microbiol Clin 2004; 22: 279–285.
- Grupo de Trabajo de Enfermedades Infecciosas de la SEMICYUC. Estudio Nacional de Vigilancia de Infección Noso-comial, en Servicios de Medicina intensiva. Report 2006.
- Alvarez-Lerma F, Nicolás-Arfelis JM, Rodriguez-Borregan JC, Diaz-Regarión J, SA-BorgesM, >Garcia-Lopez F,Allepuz-Palau A. Clinical use and tolerability of voriconazole in the treat-ment of fungal infections in critically ill patients. J Chemother 2005; 17: 417–427.
- Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–829.
- Ascioglu S, Rex JH, de Pauw B, Bennet JE, BiIle J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.
- Moran JL, Solomon PJ, Williams PJ. Assessment of out-come over a 10-year period of patients admitted a multidiscipli-nary adult intensive care unit with haematological and solid tumours. Anaesth Intensive Care 2005; 33: 26–35.
- Jordá-Marcos R, Alvarez-Lerma F, Jurado M, Palomar M, Nolla-Salas J, Le6n C, et al. Risk factors for candidaemia in crit-ically ill patients: a prospective surveillance study. Mycoses 2007; 50: 302–310.
- Bougnoux ME, Kac G, Aegerter P, d'Enfert C, Fagon JY. Candidemia and candiduria in critically ill patients admitted to in-tensive care units in France: incidence, molecular diversity, man-agement and outcome. Intensive Care Med 2007; 34: 292–299.
- Alvarez Lerma F, Palomar M, Olaechea P, Otal JJ, Insausti J, Cerdá E. National Study of Control of Nosocomial Infection in Intensive Care Units. Evolutive report of the years 2003-2005. [Article in Spanish]. Med Intensiva 2007; 31: 6–17.
- Alvarez-Lerma F, Palomar M, León C, Olaechea P, Cerdá E, Bermejo B. Fungal colonization and/or infection in intensive care units. Multicenter study of 1,562 patients. [Article in Span-ish]. Med Clin (Barc) 2003; 121: 161–166.
- Frothinghan R. Lipid formulations of amphotericin B for empiric treatment of fever and neutropenia. Clin Infect Dis 2002; 35: 896–897.
- Bellmann R, Egger P, Wiedermann CJ. Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence. Clin Infec Dis 2003; 36: 1500–1501.